Loreto Mda News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Loreto Mda. Real-time updates on events, politics, business and more.

Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio

May 25, 2024

In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1%...

United States Jonathan Graham Marlena Abdinoor Sloan Simpson Loreto Mda Parag Mahanti

Source: prnewswire.com

Novartis Pharma AG: Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio

May 25, 2024

In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine) reduction vs.

United States Sloan Simpson Nicole Zinsli Somm Lambers Heerspink Jonathan Graham Satoshi Sugimoto

Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Loreto Mda News Today

Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio

Novartis Pharma AG: Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio

Explore More Categories